ArticleVeterinary research communications2025
Establishment of an ELISA for the detection of antibodies against Stenotrophomonas maltophilia.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundStenotrophomonas maltophilia (S. maltophilia) is a conditionally pathogenic bacterium around the world. In humans, it mainly harms patients with immunodeficient or chronic diseases, leading to high mortality rate of patients with pneumonia and bacteremia. In the veterinary medicine, it caused respiratory infections or mixed infections with other common pathogens in pigs. However, infection of S. maltophilia has been overlooked and the prevalence of S. maltophilia in porcine remains unknown due to a lack of diagnosis method.
methodsIn this study, an indirect ELISA was established using the purified Phospholipase C (PLC) protein of S. maltophilia SMFZ-01 strain as the coating antigen. Checkerboard titration was performed for the optimization of the coating concentration of the recombinant PLC (rPLC) protein, the dilution and incubation time of serum and the IgG-HRP secondary antibody. The specificity, repeatability and sensitivity of established ELISA was also optimized. The positive rate of S. maltophilia antibodies was calculated using 305 clinical porcine sera samples by either established indirect ELISA or a nested PCR.
resultsrPLC was successfully purified and identified by Western blot. The optimal coating concentration of rPLC was 2.5 µg/mL. The optimal dilutions of serum samples and secondary antibody were 1:400 and 1:2500, respectively. The analytical sensitivity was 1:1600, with no cross-reaction with the positive sera of other common porcine pathogens. The intra-assay and inter-assay reproducibility coefficients of variation was less than 10%. Detection of 305 clinical porcine sera samples revealed a high positive rate by established ELISA (12.01%) and nested PCR (29.87%).
conclusionsTo our knowledge, this is the first study to develop an indirect ELISA for the detection and epidemiological analysis of S. maltophilia in porcine. Our findings indicate that S. maltophilia may be more prevalent in porcine populations than previously recognized, though further studies are needed to confirm this. The established indirect ELISA enhances our understanding of S. maltophilia infections in pig herds and provides valuable insights for designing future prevention and control strategies, along with considerations regarding the health and welfare of porcine.
Indexed as
Identifiers
40650819What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.